NCT07763379

Brief Summary

Despite advancements in surgical procedures, Anastomotic leakage (AL) remains a common complication following gastrointestinal surgery. It carries a high rate of morbidity and mortality, increases the cost of treatment, and leads to further interventions and delayed recovery. As surgical practice advances, AL becomes a significant obstacle for gastrointestinal surgeons worldwide (Smith et al., 2023). The rate of AL depends on the type of operation, the location of the anastomosis, the disease itself, the method of surgery, and patient-related factors. Patient factors that contribute to AL include malnutrition, diabetes mellitus, smoking, obesity, steroid use, emergency operations, and poor blood flow to tissues (Johnson and Lee, 2024). Even though AL begins with a small lesion in the area of the anastomosis, it can lead to extensive intra-abdominal sepsis, multiple organ failure, and death due to late diagnosis. Furthermore, in cases of oncological surgery, AL can negatively impact long-term outcomes because of delay in adjuvant treatment and increased recurrence (Brown et al., 2025). Early identification of AL is quite challenging because postoperative symptoms are nonspecific and may resemble the common inflammatory reaction after major surgery. Symptoms including fever, tachycardia, abdominal pain, ileus, leukocytosis, or purulent drainage usually become visible only when the condition is already at an advanced stage. Radiologic tests including contrast-enhanced CT are effective methods in identifying complications. However, using these techniques in every patient after major surgery is neither feasible nor economical, and some early cases may be overlooked (Wilson et al., 2023).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Aug 2026Jan 2027

First Submitted

Initial submission to the registry

August 10, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 11, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2027

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2027

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • determine the role of CRP in early diagnosis of anastomotic leakage after gastrointestinal surgery

    7 days

Study Arms (1)

THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKAGE FOLLOWING PRIMARY

Diagnostic Test: c-reactive protein

Interventions

c-reactive proteinDIAGNOSTIC_TEST

evaluate the role of postoperative CRP levels in the early diagnosis of anastomotic leakage after primary repair in gastrointestinal surgery. Additionally, the clinical utility of using serial CRP measurements as a simple, accessible, and cost-effective aid in the clinical management of patients.

THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKAGE FOLLOWING PRIMARY

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult surgical patients undergoing gastrointestinal surgery that requires a primary repair or anastomosis whether elective or emergent will be included in this study.

You may qualify if:

  • Adult patients aged 18 years or older.
  • Patients having surgery for abdominal gastrointestinal disorders (esophageal- Gastric- small bowel -colon ) where a primary repair or anastomosis is performed such (pathological -traumatic )
  • Patients fit for surgery
  • Patients who provide informed written consent.

You may not qualify if:

  • Patients younger than 18 years. 2. Patients with pre-existing systemic infection or sepsis outside GIT 3. Patients with liver cirrhosis affecting CRP synthesis. 4. Patients receiving corticosteroids or immunosuppressive therapy. 5. Patients refusing participation in the study 6. Post operative wound infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, Sohag Governorate, 82516, Egypt

RECRUITING

Related Publications (3)

  • J Clin Med. 2024;13(7):2055

    RESULT
  • updated review. World J Gastrointest Surg. 2024;16(2):88-97

    RESULT
  • Ann Surg. 2023;278(4):512-520

    RESULT

Central Study Contacts

Mahmoud Elsayed Hussein, resident

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 13, 2026

Study Start

August 11, 2026

Primary Completion (Estimated)

January 11, 2027

Study Completion (Estimated)

January 12, 2027

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations